125 related articles for article (PubMed ID: 22781396)
1. Histone deacetylase inhibitor, apicidin, inhibits human ovarian cancer cell migration via class II histone deacetylase 4 silencing.
Ahn MY; Kang DO; Na YJ; Yoon S; Choi WS; Kang KW; Chung HY; Jung JH; Min do S; Kim HS
Cancer Lett; 2012 Dec; 325(2):189-99. PubMed ID: 22781396
[TBL] [Abstract][Full Text] [Related]
2. Anti-tumor effect of apicidin on Ishikawa human endometrial cancer cells both in vitro and in vivo by blocking histone deacetylase 3 and 4.
Ahn MY; Chung HY; Choi WS; Lee BM; Yoon S; Kim HS
Int J Oncol; 2010 Jan; 36(1):125-31. PubMed ID: 19956841
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase inhibitor up-regulates RECK to inhibit MMP-2 activation and cancer cell invasion.
Liu LT; Chang HC; Chiang LC; Hung WC
Cancer Res; 2003 Jun; 63(12):3069-72. PubMed ID: 12810630
[TBL] [Abstract][Full Text] [Related]
4. HDAC4 represses p21(WAF1/Cip1) expression in human cancer cells through a Sp1-dependent, p53-independent mechanism.
Mottet D; Pirotte S; Lamour V; Hagedorn M; Javerzat S; Bikfalvi A; Bellahcène A; Verdin E; Castronovo V
Oncogene; 2009 Jan; 28(2):243-56. PubMed ID: 18850004
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase inhibitor apicidin downregulates DNA methyltransferase 1 expression and induces repressive histone modifications via recruitment of corepressor complex to promoter region in human cervix cancer cells.
You JS; Kang JK; Lee EK; Lee JC; Lee SH; Jeon YJ; Koh DH; Ahn SH; Seo DW; Lee HY; Cho EJ; Han JW
Oncogene; 2008 Feb; 27(10):1376-86. PubMed ID: 17828306
[TBL] [Abstract][Full Text] [Related]
6. Apicidin, a novel histone deacetylase inhibitor, has profound anti-growth activity in human endometrial and ovarian cancer cells.
Ueda T; Takai N; Nishida M; Nasu K; Narahara H
Int J Mol Med; 2007 Feb; 19(2):301-8. PubMed ID: 17203205
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylases 1, 6 and 8 are critical for invasion in breast cancer.
Park SY; Jun JA; Jeong KJ; Heo HJ; Sohn JS; Lee HY; Park CG; Kang J
Oncol Rep; 2011 Jun; 25(6):1677-81. PubMed ID: 21455583
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of histone deacetylase attenuates hypoxia-induced migration and invasion of cancer cells via the restoration of RECK expression.
Jeon HW; Lee YM
Mol Cancer Ther; 2010 May; 9(5):1361-70. PubMed ID: 20442303
[TBL] [Abstract][Full Text] [Related]
9. Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9.
Cheung LW; Leung PC; Wong AS
Cancer Res; 2006 Nov; 66(22):10902-10. PubMed ID: 17108127
[TBL] [Abstract][Full Text] [Related]
10. Disruption of HDAC4/N-CoR complex by histone deacetylase inhibitors leads to inhibition of IL-2 gene expression.
Matsuoka H; Fujimura T; Hayashi M; Matsuda K; Ishii Y; Aramori I; Mutoh S
Biochem Pharmacol; 2007 Aug; 74(3):465-76. PubMed ID: 17559812
[TBL] [Abstract][Full Text] [Related]
11. SULF1 inhibits tumor growth and potentiates the effects of histone deacetylase inhibitors in hepatocellular carcinoma.
Lai JP; Yu C; Moser CD; Aderca I; Han T; Garvey TD; Murphy LM; Garrity-Park MM; Shridhar V; Adjei AA; Roberts LR
Gastroenterology; 2006 Jun; 130(7):2130-44. PubMed ID: 16762634
[TBL] [Abstract][Full Text] [Related]
12. PKCepsilon is essential for gelsolin expression by histone deacetylase inhibitor apicidin in human cervix cancer cells.
Eun DW; Ahn SH; You JS; Park JW; Lee EK; Lee HN; Kang GM; Lee JC; Choi WS; Seo DW; Han JW
Biochem Biophys Res Commun; 2007 Mar; 354(3):769-75. PubMed ID: 17257588
[TBL] [Abstract][Full Text] [Related]
13. Apicidin, a histone deacetylase inhibitor, inhibits proliferation of tumor cells via induction of p21WAF1/Cip1 and gelsolin.
Han JW; Ahn SH; Park SH; Wang SY; Bae GU; Seo DW; Kwon HK; Hong S; Lee HY; Lee YW; Lee HW
Cancer Res; 2000 Nov; 60(21):6068-74. PubMed ID: 11085529
[TBL] [Abstract][Full Text] [Related]
14. Expression of cyclin D3 through Sp1 sites by histone deacetylase inhibitors is mediated with protein kinase C-delta (PKC-delta) signal pathway.
Kim YH; Lim JH; Lee TJ; Park JW; Kwon TK
J Cell Biochem; 2007 Jul; 101(4):987-95. PubMed ID: 17407153
[TBL] [Abstract][Full Text] [Related]
15. Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells.
Cheong JW; Chong SY; Kim JY; Eom JI; Jeung HK; Maeng HY; Lee ST; Min YH
Clin Cancer Res; 2003 Oct; 9(13):5018-27. PubMed ID: 14581377
[TBL] [Abstract][Full Text] [Related]
16. Apicidin is a histone deacetylase inhibitor with anti-invasive and anti-angiogenic potentials.
Kim SH; Ahn S; Han JW; Lee HW; Lee HY; Lee YW; Kim MR; Kim KW; Kim WB; Hong S
Biochem Biophys Res Commun; 2004 Mar; 315(4):964-70. PubMed ID: 14985106
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of DNA methyltransferases, histone deacetylases and lysine-specific demethylase-1 suppresses the tumorigenicity of the ovarian cancer ascites cell line SKOV3.
Meng F; Sun G; Zhong M; Yu Y; Brewer MA
Int J Oncol; 2013 Aug; 43(2):495-502. PubMed ID: 23709006
[TBL] [Abstract][Full Text] [Related]
18. [Effect of semaphorin4D gene silencing on malignant behavior of human ovarian cancer SKOV3 cells].
Chen Y; Zhang L; Wu HJ; Liu WX; Hao Q
Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):324-30. PubMed ID: 21875458
[TBL] [Abstract][Full Text] [Related]
19. Mesothelin enhances invasion of ovarian cancer by inducing MMP-7 through MAPK/ERK and JNK pathways.
Chang MC; Chen CA; Chen PJ; Chiang YC; Chen YL; Mao TL; Lin HW; Lin Chiang WH; Cheng WF
Biochem J; 2012 Mar; 442(2):293-302. PubMed ID: 21999204
[TBL] [Abstract][Full Text] [Related]
20. Arsenic trioxide (As(2)O(3)) inhibits peritoneal invasion of ovarian carcinoma cells in vitro and in vivo.
Zhang J; Wang B
Gynecol Oncol; 2006 Oct; 103(1):199-206. PubMed ID: 16624393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
